Publications
B Cells
G-Rex®10, G-Rex®100
Publication Date: May 12, 2010
SOP D03.01.23 (Center for Cell & Gene Therapy GMP Facility) defines how GMP staff generate Epstein-Barr virus-transformed lymphoblastoid cell lines (LCLs) as stimulator cells for cytotoxic T-lymphocyte (CTL) production. Starting material: fresh or frozen PBMC from the stem cell donor (ETNA protocol) or the patient (ANGEL, ANGELA or SCAEBV protocols), with donor infectious disease testing within 30 days of collection. 5 × 10^6 PBMC are infected with 200 µl of B95-8 EBV supernatant in medium with 1 µg/ml cyclosporin A, plated in 96-well plates, then moved to 24-well plates and a 25 cm2 flask with acyclovir. LCLs may be expanded in GP40 and GP500 bioreactors (about 5 × 10^7 cells by day…
Publications
CTL Cells
G-Rex®100M, G-Rex®10M, G-Rex®500M
Publication Date: April 1, 2010
Gas-permeable G-Rex® cultureware increased the output of Epstein-Barr virus-specific cytotoxic T lymphocytes (EBV-CTLs) compared with 24-well plates while cutting hands-on work. Activated CTLs seeded at 5 × 10^5 cells/cm² reached a median of 7.9 × 10^6/cm² after 3 days in the G-Rex®40 versus 1.8 × 10^6/cm² in plates, mainly through better cell survival rather than extra divisions. With an optimized feeder-to-CTL ratio, the 16-day process in G-Rex®40 then G-Rex®500 gave a median 6.5 × 10^8 cells, and splitting cultures extended growth to a median 5.07 × 10^9 cells by days 27 to 30. Phenotype, antigen specificity and cytolytic activity were unchanged. Producing 1 × 10^10 CTLs fell from abou…
Publications
Other
Publication Date: August 1, 2009
ICH Q8(R2) sets out what a manufacturer should present in the Pharmaceutical Development section of a marketing application, with the aim of designing a quality product and a process that consistently delivers its intended performance. It stresses that the knowledge gained, not the volume of data, underpins science-based submissions. The annex describes quality by design: defining a quality target product profile, identifying critical quality attributes, assessing risk to link material attributes and process parameters to those attributes, and establishing a design space and a control strategy. Greater scientific understanding can support more flexible regulatory approaches, including rea…
Publications
Other
Publication Date: January 1, 2006
Culturing pancreatic islets on top of gas-permeable silicone rubber membranes allowed a 20-fold increase in seeding density without loss of islet quality. Porcine and human islets were cultured in devices with 100 μm silicone rubber bottoms and compared with standard flasks at 200 IE/cm2 and 1 μl/IE. At 1000 to 4000 IE/cm2, gas-permeable culture gave similar fractional viability by oxygen consumption rate per DNA, higher viable tissue recovery (p=0.04), and 100% diabetes reversal in nude mice. In non-gas-permeable devices above 1000 IE/cm2, viability and recovery fell and diabetes was not reversed. Dilutions up to at least 4 μl/IE, media heights up to at least 4 cm, and 7 days without med…
Literature
T-Cells
IL-15 proved necessary to sustain T-cell growth and IL-7 necessary to hold CCR7 expression, and cells did not expand at all when both cytokines were left out. Titrating IL-7 and IL-15 each at 0, 2.5, 5, 10 or 15 ng/mL shifted fold expansion and CD127 levels while leaving the CD45RA and CCR7 memory profile largely unchanged. Overdosing IL-15 lowered the memory marker CD127, most clearly on CD8+ T cells, whereas CD127 stayed stable across the IL-7 titration. On this basis Bio-Techne released GMP IL-2, IL-7, IL-15 and IL-21 in three ready-to-use formats: closed-system ProPak bags, process-sized single-use vials and liquid vials.
Scientific Posters
G-Rex®500M-CS
Closed System G-Rex® bioreactors held their sterile fluid path intact through at least fourteen days of full immersion in a challenge solution of Brevundimonas diminuta, a 0.3 to 0.6 micrometre motile gram-negative indicator organism, with no bacterial growth recovered from nutrient broth sampled from the test vessels. G-Rex® membrane material also passed viral penetration testing to ASTM F1671, with 32 test articles pressurised to 2.0 psig against a Phi-X174 bacteriophage suspension of at least 1.0 x 10^6/mL. Ten G-Rex® 500M-CS bioreactors incubated together in a Heracell Vios CR CO2 incubator still allowed recovery of temperature, CO2 and humidity within 10 minutes, uniformity of +/- 0.…
Videos
This video animation demonstrates a vision toward the industrialization and automation of T cell therapy manufacturing using G-Rex® Bioreactors. Video was created by Wilson Wolf Manufacturing Corporation.
Videos
In this video you will learn how G-Rex® solve the limitations of flask and bag-based cell therapy manufacturing. By providing cells with uninterrupted access to oxygen and nutrients, the G-Rex® cell culture device is the only accessible cell expansion technology that linearly scales to meet the demands of cell therapy manufacturers.
Publications
CAR T Cells
G-Rex®24 Well Plate
A compact perfused microfluidic culture device (µCCD) expanded primary T cells and anti-CD19 CAR T cells to much higher cell concentrations than a 24-well G-Rex® control, though with fewer total cells. Both systems were inoculated with one million cells, a density of 0.5 × 10⁶ cells per cm², and cultured for four days. CAR T cells reached 56.5 × 10⁶ viable cells per mL in the µCCD versus 3.14 × 10⁶ in the G-Rex®, with 14.1 × 10⁶ versus 25.1 × 10⁶ total viable cells. The µCCD consumed 46.8 mL of medium per device against 14 mL per G-Rex® well. Cytotoxicity against NALM6 targets was comparable, and µCCD cultures contained a higher proportion of central memory CD8 cells.
Publications
NKT Cells
Combining IL-15 with the G-Rex® bioreactor gives an efficient way to expand human CD4-negative invariant NKT cells from healthy donor blood. PBMC were cultured for 14 days with α-GalCer and one of IL-2, IL-4, IL-7 or IL-15; IL-15 added at day 0 produced the strongest expansion of total and subset-specific iNKT cells. G-Rex® cultures outperformed expansion bags at day 14 and raised the CD4-negative fraction, which stayed stable in bags. Expanded cells produced IFN-γ and IL-4, retained perforin and granzyme B, killed THP-1 leukemia cells and induced apoptosis in allogeneic dendritic cells. In irradiated NSG mice given human PBMC, co-transfer of expanded iNKT cells improved survival (p = 0.0…
Publications
CAR T Cells
G-Rex®6 Well Plate
A long-term co-culture killing assay in the G-Rex® 6 Well Plate lets researchers follow tumor cell growth and the effect of cell therapies without media changes. Target cells engineered to express firefly luciferase are seeded with D-luciferin, and bioluminescence, which tracks cell number linearly, is imaged repeatedly. Suspension lines (THP-1, Raji, Daudi) and a solid tumor line (PANC1) grew over several days in this format. In a demonstration, anti-CD19 CAR T cells controlled lymphoma growth, but a CD19-negative population emerged after three weeks of undisturbed culture. The suggested set-up uses 100 μM D-luciferin and 35 mL of medium per well, and the assay was also applied to non-en…
Publications
CAR T Cells
G-Rex®100
A closed, integrated workflow linking the CTS DynaCellect, Rotea and Xenon systems produced gene-edited anti-CD19 CAR T cells from healthy-donor leukopaks with high viability. T cells isolated with CD3/CD28 magnetic beads were cultured for 3 days in OpTmizer Pro SFM with 100 U/mL IL-2, debeaded, washed on the Rotea system, and transferred through a welded PVC line to the Xenon system for Cas9 electroporation with a CD19 CAR DNA payload. On day 3 viability exceeded 90% and T cell content averaged 95%. After electroporation, viability averaged about 85% at day 10; about 25% and 30% of cells were CAR-positive without T cell receptor on days 3 and 10, and cultures expanded from about 10^8 to…
No manuscripts match your filters.